ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1083

Nationwide Trends in Hospitalization and in-Hospital Mortality Associated with Granulomatosis with Polyangiitis (GPA)

Zachary Wallace1, John H. Stone2, Hyon K. Choi3, Na Lu3, Sebastian Unizony3 and Eli Miloslavsky4, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 3Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Massachusetts General Hopsital, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ANCA, Epidemiologic methods, morbidity and mortality and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Granulomatosis with polyangiitis
(GPA) is associated with severe end-organ damage (e.g., renal failure) and treatment-related
complications (e.g., severe infection) which often lead to
hospitalization with
major resource use.  However, no data on hospitalization
trends and associated mortality are available.  We evaluated recent trends in nationwide
hospitalization and in-hospital mortality among patients with GPA. 

Methods: We
used the National Inpatient Survey (NIS) which is the
largest all-payer inpatient database in the US and includes data and sampling
weights from over 1,200 hospitals across 44 states. We studied all hospitalizations
of adults (³18 years) with a primary discharge diagnosis of GPA (ICD 9: 446.4)
between 2001 and 2011.  We
investigated trends in hospitalization and mortality by comparing GPA to
overall inpatient hospitalization trends. 
All analyses were performed using hospital-level sampling weights
provided by the NIS to obtain US national estimates.

Results: From
2001 to 2011, the rate of hospitalization for GPA remained stable from
0.76/100,000 persons to 0.78/100,000 persons.  The mean age tended to get younger from
56.9 yrs to 55.1 yrs and there was a slight male
predominance (40.6% +/- 3.1 vs. 50.0% +/- 2.9; P-for-trend=0.0001) over the
study period. From 2001 to 2011, the mean length of stay remained stable,
between 9.7 +/- 0.6 and 8.6 +/- 0.5 days (P-for-trend 0.24), but there was a
significant decline in in-hospital death from 7.7% (+/-2.7%) in 2001 to 2.6%
(+/-1.5%) in 2011 (Figure 1)
(P-for-trend < 0.0001). Overall, the annual relative change in GPA mortality
was -9.96% (95% CI: -14.3 to -5.6) and the annual absolute change was -0.46%
(95% CI: -0.66% to -0.25%). This was a significantly greater decline than
overall inpatient hospitalization mortality (annual relative change of -2.5%
95% CI -2.7% to -2.2% and annual absolute change of -0.06%, 95% CI: -0.06% to
-0.05%). Among those who died during a hospitalization when GPA was the primary
diagnosis in 2011, the most common secondary diagnoses were respiratory
failure, chronic kidney disease, and lower respiratory disease. 

Conclusion:
Between 2001 and 2011, hospitalization and length of stay for GPA remained
stable but in-hospital mortality declined in this dataset representative of all
US hospitalizations. This decline was significantly greater than that of the
background US in-hospital mortality rate. The declining in-hospital mortality
rate may be due to earlier recognition of GPA, shifts in treatment that
emphasize less cyclophosphamide use and more tempered use of glucocorticoids,
and secular trends in the management of infections and end-organ
complications.

FIGURE
1: Nationwide Trends in In-Hospital Mortality of GPA Patients


Disclosure: Z. Wallace, None; J. H. Stone, Roche, Genentech, 2,Genentech, 5; H. K. Choi, None; N. Lu, None; S. Unizony, None; E. Miloslavsky, Genentech Inc., 2.

To cite this abstract in AMA style:

Wallace Z, Stone JH, Choi HK, Lu N, Unizony S, Miloslavsky E. Nationwide Trends in Hospitalization and in-Hospital Mortality Associated with Granulomatosis with Polyangiitis (GPA) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/nationwide-trends-in-hospitalization-and-in-hospital-mortality-associated-with-granulomatosis-with-polyangiitis-gpa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nationwide-trends-in-hospitalization-and-in-hospital-mortality-associated-with-granulomatosis-with-polyangiitis-gpa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology